Mrs. Sara Schweigert Rickman, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2461 Sw Perkins Ave, Pendleton, OR 97801 Phone: 541-276-0250 Fax: 541-276-0253 |
Rhonda Lynn Wyland, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2461 Sw Perkins Ave, Pendleton, OR 97801 Phone: 541-276-0250 Fax: 541-276-0253 |
Mrs. Janet Adele Penny, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 Se Court Pl, L01, Pendleton, OR 97801 Phone: 541-276-0250 Fax: 541-276-0253 |
Mr. Donald Clifford Guenther, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1600 Se Court Pl, Pendleton, OR 97801 Phone: 541-276-0250 Fax: 541-276-0253 |
News Archive
Since the completion of the human genome sequence, a question has baffled researchers studying gene control: How is it that humans, being far more complex than the lowly yeast, do not proportionally contain in our genome significantly more gene-control proteins?
A new study, the first of its kind, combines two complementary analytical brain imaging techniques, to provide a more comprehensive and accurate picture of the neuroanatomy of the autistic brain. The study, published in the April issue of neuroimaging journal Human Brain Mapping, was conducted by researchers at The Montreal Neurological Institute and Hospital - The Neuro, McGill University and the Universit- de Montr-al.
A study by an international research group identified 15 novel biomarkers that are linked to late-onset dementias. These biomarkers are proteins, which predict cognitive decline and subsequent increased risk of dementia already 20 years before the disease onset.
As the COVID-19 pandemic continues to grow, scientists are focusing on understanding how the host immune system responds to the virus in order to better shape public health responses and develop effective vaccines. A new study published on the preprint server medRxiv in September 2020 reports the T cell memory response to the SARS-CoV-2 spike protein, recombinant nucleocapsid protein, and other pooled peptides derived from convalescent patients.
Researchers at Washington University School of Medicine in St. Louis have shed new light on a process that fixes breaks in the genetic material of the body's cells. Their findings could lead to ways of enhancing chemotherapy drugs that destroy cancer cells by damaging their DNA.
› Verified 6 days ago